Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Cardiol Therapeutics Inc logo

Cardiol Therapeutics Inc

Sector: Manufacturing   

Industry: Medicinal and Botanical Manufacturing

1.67
 
USD
  
-0.08
  
(-4.57%)
Optionable: Yes  Market Cap: 112 M  90-day average vol: 394,387

Previous close: 1.75  Open: 1.75  Bid: 1.67  Ask: 1.74
52 week range    
0.52   
   2.17
Peers   
Last updated: Friday 19th April 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

CRDL Income Statement

Annual
Invalid dateDec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles84444.084444.084444.084444.0
Basic EPS from continuing operations-1.03-0.53-0.69-0.73-0.49
Basic EPS total-1.03-0.53-0.69-0.73-0.49
Basic weighted shares outstanding15 M26 M30 M43 M63 M
Depreciation7048.066128.0145095.0135464.0
Depreciation unreconciled91492.0150572.0229539.0219908.0
DepreciationAndAmortization91492.0150572.0229539.0219908.0
Diluted EPS total-1.03-0.53-0.69-0.73-0.49
Diluted normalized net income/share-1.03-0.53-0.69-0.73-0.49
Diluted weighted shares outstanding15 M26 M30 M43 M63 M
GainOnSaleOfSecurity-8 M-99850.0-34455.07 M
GeneralAndAdministrativeExpense6 M10 M10 M28 M18 M
Income before tax-16 M-14 M-21 M-32 M-31 M
Interest income103306.0245422.076583.0106001.01 M
InterestExpenseNonOperating663373.0621.0
MiscOtherSpecialCharges164443.0
Net income from total operations-16 M-14 M-21 M-32 M-31 M
NetIncomeCommonStockholders-16 M-14 M-21 M-32 M-31 M
NetIncomeContinuousOperations-16 M-14 M-21 M-32 M-31 M
NetNonOperatingInterestIncomeExpense560067.0-244801.0-76583.0-106001.01 M
Normalized income-12 M-10 M-15 M-23 M-23 M
Operating income-7 M-14 M-21 M-39 M-41 M
Operating income before depreciation (EBITDA)-15 M-14 M-20 M-31 M-31 M
OperatingExpense7 M14 M21 M39 M41 M
Other income net-8 M198945.0-27057.07 M-6 M
OtherGandA6 M10 M10 M28 M18 M
Research & development expense2 M4 M11 M11 M18 M
ResearchExpense18 M
Revenue per share84444.084444.084444.084444.0
SalariesAndWages3 M5 M5 M5 M
SecuritiesAmortization663373.0
Selling Gen & administrative expense6 M10 M10 M28 M18 M
Total Income available for interest expense (EBIT)-15 M-14 M-21 M-32 M-31 M
Total common shares outstanding23 M26 M33 M61 M43 M
Total net income-16 M-14 M-21 M-32 M-31 M
Total ordinary shares65 M65 M65 M65 M65 M
Total revenues78760.0
TotalExpenses-7 M-14 M-21 M-39 M41 M
TotalRevenue78760.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University